197
Views
25
CrossRef citations to date
0
Altmetric
Original Research

Improved pharmacokinetics and reduced toxicity of brucine after encapsulation into stealth liposomes: role of phosphatidylcholine

, , , , , , & show all
Pages 3567-3577 | Published online: 26 Jul 2012

References

  • PhilippeGAngenotLTitsMFrédérichMAbout the toxicity of some Strychnos species and their alkaloidsToxicon200444440541615302523
  • DengXKYinWLiWDThe anti-tumor effects of alkaloids from the seeds of Strychnos nux-vomica on HepG2 cells and its possible mechanismJ Ethnopharmacol2006106217918616442763
  • YinWDengXKYinFZZhangXCCaiBCThe cytotoxicity induced by brucine from the seed of Strychnos nux-vomica proceeds via apoptosis and is mediated by cyclooxygenase 2 and caspase 3 in SMMC 7721 cellsFood Chem Toxicol20074591700170817449162
  • RaoPSRamanadhamMPrasadMNAnti-proliferative and cytotoxic effects of Strychnos nux-vomica root extract on human multiple myeloma cell line – RPMI 8226Food Chem Toxicol200947228328819027818
  • AgrawalSSSaraswatiSMathurRPandeyMCytotoxic and antitumor effects of brucine on Ehrlich ascites tumor and human cell lineLife Sci2011895–614715821684292
  • MaloneMHSt John-AllanKMBejarEBrucine lethality in miceJ Ethnopharmacol19923532952971347799
  • ZhangLHanLSunXGaoDQinJWangJThe use of PEGylated liposomes to prolong the circulation lifetime of salvianolic acid BFitoterapia2252012 [Epub ahead of print.]
  • SeniorJGregoriadisGIs half-life of circulating liposomes determined by changes in their permeability?FEBS Lett198214511091146897042
  • YangXZhaoXPhelpsMAA novel liposomal formulation of flavopiridolInt J Pharm20093651–217017418778761
  • PaolinoDCoscoDRacanicchiLGemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activityJ Control Release2010144214415020184929
  • ZamboniWCStrychorSJosephEPlasma, tumor, and tissue distribution of STEALTH liposomal CKD-602 (S-CKD602) and nonliposomal CKD-602 in mice bearing A375 human melanoma xenograftsClin Cancer Res200713237217722318056203
  • ChenJLinAChenZAmmonium sulfate gradient loading of brucine into liposomes: effect of phospholipid composition on entrapment efficiency and physicochemical properties in vitroDrug Dev Ind Pharm201036324525319678739
  • ChenJXiaoHLHuRRPharmacokinetics of brucine after intravenous and oral administration to ratsFitoterapia20118281302130821958965
  • RosielloAPEssignmannJMWoganGNRapid and accurate determination of the median lethal dose (LD50) and its error with a small computerJ Toxicol Environ Health19773797809599579
  • DjanashviliKten HagenTLBlangéRSchipperDPetersJAKoningGADevelopment of a liposomal delivery system for temperature-triggered release of a tumor targeting agent, Ln(III)-DOTA-phenylboronateBioorg Med Chem20111931123113020624680
  • ChouTHChenSCChuIMEffect of composition on the stability of liposomal irinotecan prepared by a pH gradient methodJ Biosci Bioeng200395440540816233428
  • QinXQYuanYLiuCSPreparation of liposomal brucine and its pharmaceutical/pharmacodynamic characterizationActa Pharmacol Sin200728111851185817959038
  • MercadalMDomingoJCBermudezMMoraMDe MadariagaMAN-palmitoylphosphatidylethanolamine stabilizes liposomes in the presence of human serum: effect of lipidic composition and system characterizationBiochim Biophys Acta1995123522812887756336
  • MoghimiSMSzebeniJStealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding propertiesProg Lipid Res200342646347814559067